On March 18, the Food and Drug Administration (FDA) conducted an inspection of Glytec, LLC. in Greenville, data from the FDA’s website show.
The inspection included the following topics:
- Compliance: Devices
- Postmarket Assurance: Devices
The final report concluded that Glytec, LLC. does not need to take corrective action regarding the organization’s management operations.
The FDA regularly inspects facilities nationwide to verify whether workplaces and products comply with FDA regulations designed to safeguard public health. Results of these inspections are made available to the public.
As described on its website, the FDA is a federal agency tasked primarily with regulating the safety and quality of human and animal drugs, biological products, medical supplies, and tobacco products.
Information in this article was obtained from the U.S. Food and Drug Administration. The source data can be found here.
